Since adult hippocampal neurogenesis is impaired during aging and neurodegenerative diseases such as Alzheimer’s diseases, targeting Prdm16 could be a novel approach to enhance plasticity in the diseased brain. Here, PRDM16 is linked to Alzheimer disease.